A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines
International Journal of Molecular Sciences · 27.04.2023 · 24 (9) · 7929
DOI: 10.3390/ijms24097929 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.04.2023. Verfasst von Barbara Brandt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology and Central Electron Microscopic Laboratory, Medical School, University of Pécs, 7624 Pécs, Hungary. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pécs Medical School, Medical School, University of Pécs.
Abstract (Originalsprache)
There is no effective therapy for the lately increased incidence of glioblastoma multiforme (GBM)—the most common primary brain tumor characterized by a high degree of invasiveness and genetic heterogeneity. Currently, DNA alkylating agent temozolomide (TMZ) is the standard chemotherapy. Nevertheless, TMZ resistance is a major problem in the treatment of GBM due to numerous molecular mechanisms related to DNA damage repair, epigenetic alterations, cellular drug efflux, apoptosis-autophagy, and overactive protein neddylation. Low molecular weight inhibitors of NEDD8-activating enzyme (NAE), such as MLN4924, attenuate protein neddylation and present a promising low-toxicity anticancer agent. The aim of our study was to find an effective combination treatment with TMZ and MLN4924 in our TMZ-resistant GBM cell lines and study the effect of these combination treatments on different protein expressions such as O6-methylguanine methyltransferase (MGMT) and p53. The combination treatment successfully decreased cell viability and sensitized TMZ-resistant cells to TMZ, foreshadowing a new treatment strategy for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology and Central Electron Microscopic Laboratory, Medical School, University of Pécs, 7624 Pécs, Hungary.
- Department of Ecology, Faculty of Sciences, University of Pécs, 7624 Pécs, Hungary.
- Department of Medical Biology and Genetics, Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, Croatia.
- Department of Biochemistry and Medical Chemistry, Medical School, University of Pécs, 7624 Pécs, Hungary.
ORCID-Profile: Marija Heffer, Marianna Pap
Förderung
- University of Pécs Medical School
- Medical School, University of Pécs
Zitieren
APA
Brandt, B., Németh, M., Berta, G., Szünstein, M., Heffer, M., Rauch, T. A., & Pap, M. (2023). A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines. International Journal of Molecular Sciences, 24(9), 7929. https://doi.org/10.3390/ijms24097929
Vancouver
Brandt B, Németh M, Berta G, Szünstein M, Heffer M, Rauch TA, et al. A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines. International Journal of Molecular Sciences. 2023;24(9):7929. doi:10.3390/ijms24097929
BibTeX
@article{Brandt2023,
author = {Brandt, Barbara and Németh, Marica and Berta, Gergely and Szünstein, Máté and Heffer, Marija and Rauch, Tibor A and Pap, Marianna},
title = {A Promising Way to Overcome Temozolomide Resistance through Inhibition of Protein Neddylation in Glioblastoma Cell Lines},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {9},
pages = {7929},
doi = {10.3390/ijms24097929}
}
EUVIMED